| Value | ₹5.14 Cr |
|---|
BSE filing, NSE: INDUSFINL. Summary written from the filing by ALFA Finder's alert engine.
Indus Finance Ltd: key numbers
- Share price
- ₹347.90
- Market cap
- ₹322.1 Cr
- Revenue (annual)
- ₹9.36 Cr
- Net profit (annual)
- ₹2.01 Cr
- P/E (TTM)
- 124.3×Sector 19.7×
- Promoter holding
- 74.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indus Finance Ltd
All →Indus Finance Management Change
Indus Finance Limited has appointed S. Vasudevan & Associates as its new internal auditor following the resignation of the incumbent, Kailash Jain and Associates, effective October 14, 2026.
Indus Finance Bonus Issue
Indus Finance Limited's board recommended a 5:9 bonus equity share issue. Shareholders will vote on this proposal on November 20, 2026.
Indus Finance Q2 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY
Indus Finance Ltd reported revenue from operations of ₹1.3 Cr (+18.2% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr · +0.0% YoY
Indus Finance Other Announcement
The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI Regulation 31(1)(b).
Indus Finance Board Meeting Date
Indus Finance Limited scheduled a board meeting for October 14, 2026, to discuss potential bonus issues and unaudited financial results for the period ended September 2026.
Indus Finance Bonus Issue
Indus Finance Ltd scheduled a board meeting for October 14, 2026, to consider quarterly financial results and a proposal for a bonus share issue.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.